SOSV

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.

All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.

Aksense is an innovative company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. Its flagship product is the first portable rapid infection diagnostic biosensor designed to improve healthcare quality and safety. By facilitating early detection and treatment of infections, Aksense's technology aims to enhance antibiotic prescribing practices and reduce the spread of infections. This approach not only improves patient outcomes but also supports public health initiatives by allowing users to recover faster through cost-effective molecular testing solutions.

Carv is the first wearable dedicated to skiing that speaks to you as you ski - it’s your digital ski coach. Built in consultation with Olympians, Carv gives you access to the feedback and knowledge that only elite skiers have had access to so far. With an extremely thin smart insert, Carv measures your motion and pressure distribution and relays feedback through your earphones in real-time. Carv connects wirelessly to your smartphone to give simple, actionable feedback to casual skiers and detailed metrics and analysis for advanced and professional skiers. Carv lets you train, compete and challenge people with its detailed metrics and helps you improve your skiing with technique analysis.

Unicorn Biotechnologies is developing a fully automated manufacturing platform to enable cellular agriculture producers to seamlessly scale products from the lab bench to supermarket shelves. Our full stack platform combines hardware, software and analytics to completely automate cellular agriculture manufacturing, reducing costs and increasing product quality. By providing a clear path to scale cellular agriculture from grams to tons, we will improve human and planetary health and drive the transition to animal free agriculture.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

VemiCo is a biotechnology company.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

Reach Industries focuses on developing cutting-edge products for companies. Reach Industries was founded in 2020 and was headquartered in Bristol, UK.

Asset Direct is a financial solutions company at the forefront of technological advancements. Founded in 2015 and is based in London, Ontario.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

CoffeeExchange is a digital platform based in Shanghai, China, that connects coffee farmers directly with roasters, aiming to enhance transparency in the coffee industry. Established in 2018, the company utilizes technology to streamline the green coffee trading process, offering services such as coffee evaluation, logistics, customs clearance, quality inspections, and marketing support. By eliminating intermediaries, CoffeeExchange facilitates direct trade, allowing coffee producers to earn significantly higher revenues while providing roasters with a broader selection at reduced costs. The platform incorporates IoT supply chain tracking and freight consolidation to optimize logistics and enhance order management. Currently, CoffeeExchange has over 1,100 coffee roasters in China trading with selected producers from various countries, including Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador, and is in the process of expanding its operations to the USA, UK, and South Korea.

Thingthing Ltd. is a 5 years old startup helping users elevate their typing experience on smartphones thanks to the Fleksy keyboard, one of the world's first & most popular virtual keyboards on iOS & Android. The company also serves a countless number of small, medium and large companies worldwide thanks to the powerful Fleksy keyboard SDK, which has grown significantly in the past years.

Kyomei develops a meat protein production system using plant cell biology. It uses sustainable ways to add flavor on meat-based alternatives. Kyomei was founded in 2021 and is based in Oxford, England.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Circadia fuses light science with sleep science to help adjust your body clock. Their flagship products include a non-contact sleep tracker for sleep diagnostics and a portable light therapy device for treatment. The devices sync together for an automatic and customised sleep improvement programme. Team from Imperial College London. Accelerated by HAX. Mentored by Johnson & Johnson Innovation. Launching on Kickstarter in March 2017.

Asset Direct is a financial solutions company at the forefront of technological advancements. Founded in 2015 and is based in London, Ontario.

Asset Direct is a financial solutions company at the forefront of technological advancements. Founded in 2015 and is based in London, Ontario.

Asset Direct is a financial solutions company at the forefront of technological advancements. Founded in 2015 and is based in London, Ontario.

Kutanios is a biotechnology firm focused on creating new compounds for anti-aging, sun care, anti-acne, and skin cleaning items. Headwuartered in London.

Kutanios is a biotechnology firm focused on creating new compounds for anti-aging, sun care, anti-acne, and skin cleaning items. Headwuartered in London.

Untap Water provides wastewater data to support community health. Headquartered in London.

Thingthing Ltd. is a 5 years old startup helping users elevate their typing experience on smartphones thanks to the Fleksy keyboard, one of the world's first & most popular virtual keyboards on iOS & Android. The company also serves a countless number of small, medium and large companies worldwide thanks to the powerful Fleksy keyboard SDK, which has grown significantly in the past years.

Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.

Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Caura is the payment platform for your car to manage parking, tolls, congestion charge, MOTs, vehicle tax, and insurance. Caura Protect is an FCA registered product with seven insurers, allowing drivers to purchase and manage motor insurance. Caura Maintain seamlessly manages MOTs and vehicle servicing.

Verifoxx is an AIoT blockchain company that enables easy and secure identity verification of customers. The company's platform offers a mobile app that makes an individual securely use one set of documents to verify his identity to various businesses that may require it while not sharing personal data, enabling businesses to execute a secured identity verification by not requiring customers to input or reveal their card details or personal information. The company is based in London, London in 2019.

Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.

Neurocess offers services as a wearable technology product that increases the training performance and reduces the risk of injury by analyzing the muscle of professional athletes.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Unicorn Biotechnologies is developing a fully automated manufacturing platform to enable cellular agriculture producers to seamlessly scale products from the lab bench to supermarket shelves. Our full stack platform combines hardware, software and analytics to completely automate cellular agriculture manufacturing, reducing costs and increasing product quality. By providing a clear path to scale cellular agriculture from grams to tons, we will improve human and planetary health and drive the transition to animal free agriculture.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Biomage specializes in single-cell analysis transforming the life sciences. Our goal is to apply innovative computational methods to extract valuable insight from biological data, fueling cutting-edge research across biological disciplines. Our flagship product, the Biomage Single Cell Platform empowers researchers to take ownership of their single cell data analysis, generating deep biological insight in just a few clicks.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms to create innovative plant-inspired proteins, such as brazzein, for applications in the food and beverage industries. Additionally, Magellan Life Sciences offers the XSeed platform, which leverages synthetic biology to advance the development of novel proteins aimed at enhancing the food, health, and nutrition sectors.

Carv is the first wearable dedicated to skiing that speaks to you as you ski - it’s your digital ski coach. Built in consultation with Olympians, Carv gives you access to the feedback and knowledge that only elite skiers have had access to so far. With an extremely thin smart insert, Carv measures your motion and pressure distribution and relays feedback through your earphones in real-time. Carv connects wirelessly to your smartphone to give simple, actionable feedback to casual skiers and detailed metrics and analysis for advanced and professional skiers. Carv lets you train, compete and challenge people with its detailed metrics and helps you improve your skiing with technique analysis.

Aō Air is working to enable those in polluted megacities from Beijing to London to take back the streets. Our patented technology is independently validated to be up to 50x better than leading masks on the market.

Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.

Arthronica Ltd is a London-based company that develops an artificial intelligence platform focused on patient monitoring and rehabilitation. Founded in 2018, the company specializes in solutions such as skeletal tracking, visual strength assessment, image analysis, and video analysis. Its innovative technology aims to validate algorithms capable of monitoring and predicting key disease activities in chronic rheumatic conditions. Currently, Arthronica is engaged in clinical trials in both the United Kingdom and the United States, further advancing its research and application in the medical field.

MOONA S.A.S. develops a product that enhances the quality of sleep by setting the perfect temperature to fall asleep quickly. The company was incorporated in 2016 and is based in Paris, France.

BrightCure Ltd. develops probiotic-based therapies for the treatment of urinary tract infections (UTIs). It offers products for the treatment of recurrent and difficult-to-treat bacterial infections. The company was incorporated in 2019 and is based in London, United Kingdom.

Spintex produces a low-cost and sustainable biomaterial platform for spinning high-performance silk fibers. Using a biomimetic process, and alternative proteins, Spintex reduces the energy requirements for producing silk fibers for sustainable fashion, and produce fibers with characteristics for advanced applications, that are cost-effective and scalable.

BrightCure Ltd. develops probiotic-based therapies for the treatment of urinary tract infections (UTIs). It offers products for the treatment of recurrent and difficult-to-treat bacterial infections. The company was incorporated in 2019 and is based in London, United Kingdom.

BrightCure Ltd. develops probiotic-based therapies for the treatment of urinary tract infections (UTIs). It offers products for the treatment of recurrent and difficult-to-treat bacterial infections. The company was incorporated in 2019 and is based in London, United Kingdom.

Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.

Liberum was founded in September 2007 as an investment banking firm based in London, focusing on providing a different style of broking in an industry often criticized for poor treatment of clients and staff. The firm aimed to build trust by understanding client needs and fostering a supportive environment for its employees, encouraging their ideas and professional development. It offered a range of services, including capital raising, initial public offerings, mergers and acquisitions, corporate broking, and investment management, catering to various sectors such as aerospace, agriculture, media, pharmaceuticals, and real estate. Over the years, Liberum expanded its team, adding analysts and sales staff to enhance its coverage and provide innovative insights for investors. However, it has since merged and is no longer active.

Liberum was founded in September 2007 as an investment banking firm based in London, focusing on providing a different style of broking in an industry often criticized for poor treatment of clients and staff. The firm aimed to build trust by understanding client needs and fostering a supportive environment for its employees, encouraging their ideas and professional development. It offered a range of services, including capital raising, initial public offerings, mergers and acquisitions, corporate broking, and investment management, catering to various sectors such as aerospace, agriculture, media, pharmaceuticals, and real estate. Over the years, Liberum expanded its team, adding analysts and sales staff to enhance its coverage and provide innovative insights for investors. However, it has since merged and is no longer active.

HausBots Limited, founded in 2017 and based in Birmingham, United Kingdom, specializes in designing and manufacturing wall-climbing robots for various industrial applications. Their primary product, the V1 Wall Climbing Robot, is engineered to navigate rough surfaces, making it suitable for exterior and warehouse painting, as well as high-definition visual inspections and building infrastructure surveys. The company's innovative technology aims to enhance the maintenance and protection of the built environment.

Multus Media enables cultivated meat companies to scale affordably and profitably. We take care of the growth media, so our customers can focus on bringing delicious, sustainable meat to the world. Taking a machine learning-based approach we can design a completely animal-free growth media that is tailored for animal cells. This is particularly useful for the cultivated meat industry where there are needs of high performance at large scale. Multus Media was established in 2019 and is headquartered in London, England.

Biomage specializes in single-cell analysis transforming the life sciences. Our goal is to apply innovative computational methods to extract valuable insight from biological data, fueling cutting-edge research across biological disciplines. Our flagship product, the Biomage Single Cell Platform empowers researchers to take ownership of their single cell data analysis, generating deep biological insight in just a few clicks.

Scindo is a cleantech start-up harnessing the power of enzymes to recycle the unrecyclables. We are targeting plastics that cannot be efficiently recycled with current methodologies, to turn them into high-value molecules that can be used in a plethora of industries. We are creating a more circular economy for plastics by developing an alternative to landfills and incineration.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Contents First is the team behind Tappytoon, the premier digital-first comics platform that has become a daily destination for more than 3 Million readers hailing from over 190 countries. Since January 2019, Tappytoon is the #1 to #5 top Comics app by gross revenue on Google Play and App Store in 90 countries including US, UK, Canada, Australia, Germany, and many more. (source: Google Play, Apple, AppAnnie) The Tappytoon library is now available in English, French, and German, spanning exclusive, licensed hits curated from the largest publishers in Korea and Asia, including Kakao, Haksan, Seoul Media, D&C Media, Mr Blue, Jaedam, Comico as well as K-drama/K-pop tie-ins, TV and game adaptations. Premium paywall & free digital comics are available on Web, iPhone, Android. Among the titles beloved by millions are Solo Leveling, The Abandoned Empress, Light & Shadow, Bloody Sweet, and What's Wrong with Secretary Kim, and many more. Launched in 2016, Tappytoon’s vetted translations and chart-topping smartphone apps offer the best way to read full-color digital manga, manhwa and webtoons while supporting the artists, creators, and storytellers. Tappytoon also produces a number of brand-new original comics with select partners and creators, for print, transmedia, film/tv/ani production, distrib/licensing rights.

Aō Air is working to enable those in polluted megacities from Beijing to London to take back the streets. Our patented technology is independently validated to be up to 50x better than leading masks on the market.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

eFanswer LTD owns and operates a platform that helps users to interact with celebrities, discover all the curiosity, and create a unique e-book with questions. Its product helps celebrities, through crowd writing, share their life stories with fans via text, audio, and video content across social platforms online and offline around the world. The company was founded in 2014 and is based in London, United Kingdom.

Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.

Our team hails from Italy, Taiwan, USA, and the UK with tech backgrounds from NTU (臺大) and MIT (麻省理工)。 We are alumni of Silicon Valley backed MOX Accelerator and recently closed Series A venture funding from Taipei based Darwin Ventures. We're also backed by several notable angel investors and advisors, including Duncan Clark (Alibaba), Chris Reitermann (CEO Ogilvy Asia), Olivier Glauser (Steamboat Capital, Qualcomm Ventures). Our clients are world leading game publishers from across the Americas, Europe and Asia. Started by an international team of AI experts and mobile gaming fanatics, Bubbleye is a fast growing AI startup now with R&D headquarters in Taipei and biz dev teams working across the globe. We are solving mobile user acquisition inefficiencies through automation and inferential algorithms. And to achieve that, we pick the best of the best. A select team with an international DNA, a very open culture mix across nations and continents, driven by the same powerful driving force: a passion for innovation and growth, guts to disrupt, and skills to implement. We are ahead of the global race to solving mobile user acquisition, with unique tech and talent.

Breather Products Inc. is a provider of on-demand private workspaces designed for productivity, allowing clients to reserve and unlock spaces through its web and mobile applications. Founded in 2012 and based in Montreal, Canada, the company has established a network of hundreds of locations across major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London. Breather offers flexible workspace solutions available by the hour, day, or month, catering to businesses seeking comfortable and private environments. Each space is equipped with technology that facilitates seamless work experiences, enabling users to engage in meetings or video conferences without delay.

Aksense is an innovative company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. Its flagship product is the first portable rapid infection diagnostic biosensor designed to improve healthcare quality and safety. By facilitating early detection and treatment of infections, Aksense's technology aims to enhance antibiotic prescribing practices and reduce the spread of infections. This approach not only improves patient outcomes but also supports public health initiatives by allowing users to recover faster through cost-effective molecular testing solutions.

Chemicle is developing a cost effective and clean chemical process to convert dairy waste into bio-plastic precursors. These are the building blocks of high-performance and totally recyclable plastics, whose production could decrease emissions during the manufacturing phase up to 70%.

ai nutrition develops an AI that automates online grocery shopping and precision nutrition for better health outcomes.

VemiCo is a biotechnology company.

Arthronica Ltd is a London-based company that develops an artificial intelligence platform focused on patient monitoring and rehabilitation. Founded in 2018, the company specializes in solutions such as skeletal tracking, visual strength assessment, image analysis, and video analysis. Its innovative technology aims to validate algorithms capable of monitoring and predicting key disease activities in chronic rheumatic conditions. Currently, Arthronica is engaged in clinical trials in both the United Kingdom and the United States, further advancing its research and application in the medical field.

Volatile unlocks the world of digital scent sensing and offers a novel technological solution that uses multiple layers of machine learning algorithms. They use a unique odor sensor technology that tracks all steps of the food and beverage production process to detect flavor defects that gives consistent response to defects that allows it to increase overall panel accuracy.

CorNatural develops bio-based sustainable products to offer a range of natural products. The company aims to upcycle waste streams into value-added products, using pioneering synthetic biology and genetic engineering techniques. CorNatural was founded in 2019 and is headquartered in London.

Rize is a virtual marketplace for clinical trials. It is a patient management platform used to reinvent how patients and researchers interact. The company's patient-centric platform matches people with the appropriate clinical trial and offers the ability to participate digitally. Rize Health was founded in 2019 and is headquartered in London, Ontario.

Pushme Inc. is a manufacturer of swappable batteries specifically designed for bicycles, aiming to enhance urban mobility. Founded in 2016 and based in Bath, United Kingdom, the company operates as a subsidiary of Tier Mobility GmbH. Pushme focuses on addressing the challenges of energy distribution for small electric vehicles by establishing a network of battery swap stations. These stations allow local merchants to sell energy, providing convenient and instant recharging solutions across cities. The innovative approach not only supports the adoption of electric bicycles but also empowers individuals with access to electricity to contribute to sustainable transport. The team at Pushme comprises engineers, designers, and operations experts dedicated to developing efficient hardware solutions that improve cycling experiences and facilitate energy management.

Sana Health UK Limited develops a sleep mask for people with severe sleep problems caused by high anxiety or pain. The company offers Sana, a wearable device that allows the wearer to put themselves to sleep in 10 minutes. Its mask measures and tracks user’s overall state of health and vitality over time, and uses this measure to tailor the device to get user to deep relaxation and sleep fast. Sana Health UK Limited was founded in 2015 and is based in Dorchester, United Kingdom.

CoffeeExchange is a digital platform based in Shanghai, China, that connects coffee farmers directly with roasters, aiming to enhance transparency in the coffee industry. Established in 2018, the company utilizes technology to streamline the green coffee trading process, offering services such as coffee evaluation, logistics, customs clearance, quality inspections, and marketing support. By eliminating intermediaries, CoffeeExchange facilitates direct trade, allowing coffee producers to earn significantly higher revenues while providing roasters with a broader selection at reduced costs. The platform incorporates IoT supply chain tracking and freight consolidation to optimize logistics and enhance order management. Currently, CoffeeExchange has over 1,100 coffee roasters in China trading with selected producers from various countries, including Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador, and is in the process of expanding its operations to the USA, UK, and South Korea.

ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.

Caura is the payment platform for your car to manage parking, tolls, congestion charge, MOTs, vehicle tax, and insurance. Caura Protect is an FCA registered product with seven insurers, allowing drivers to purchase and manage motor insurance. Caura Maintain seamlessly manages MOTs and vehicle servicing.

Our team hails from Italy, Taiwan, USA, and the UK with tech backgrounds from NTU (臺大) and MIT (麻省理工)。 We are alumni of Silicon Valley backed MOX Accelerator and recently closed Series A venture funding from Taipei based Darwin Ventures. We're also backed by several notable angel investors and advisors, including Duncan Clark (Alibaba), Chris Reitermann (CEO Ogilvy Asia), Olivier Glauser (Steamboat Capital, Qualcomm Ventures). Our clients are world leading game publishers from across the Americas, Europe and Asia. Started by an international team of AI experts and mobile gaming fanatics, Bubbleye is a fast growing AI startup now with R&D headquarters in Taipei and biz dev teams working across the globe. We are solving mobile user acquisition inefficiencies through automation and inferential algorithms. And to achieve that, we pick the best of the best. A select team with an international DNA, a very open culture mix across nations and continents, driven by the same powerful driving force: a passion for innovation and growth, guts to disrupt, and skills to implement. We are ahead of the global race to solving mobile user acquisition, with unique tech and talent.

Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.

Pushme Inc. is a manufacturer of swappable batteries specifically designed for bicycles, aiming to enhance urban mobility. Founded in 2016 and based in Bath, United Kingdom, the company operates as a subsidiary of Tier Mobility GmbH. Pushme focuses on addressing the challenges of energy distribution for small electric vehicles by establishing a network of battery swap stations. These stations allow local merchants to sell energy, providing convenient and instant recharging solutions across cities. The innovative approach not only supports the adoption of electric bicycles but also empowers individuals with access to electricity to contribute to sustainable transport. The team at Pushme comprises engineers, designers, and operations experts dedicated to developing efficient hardware solutions that improve cycling experiences and facilitate energy management.

Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.

Chronomics Ltd, established in 2017 and headquartered in Norwich, United Kingdom, specializes in testing kits and an artificial intelligence platform designed for DNA methylation analysis. The company focuses on monitoring users' health and wellbeing by utilizing epigenetic information derived from DNA. Its offerings include insights into biological age, smoke exposure, metabolic state, health risks, and hereditary intolerances, along with predictions related to eye color. Through its innovative approach, Chronomics aims to provide a comprehensive understanding of individual health profiles.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Circadia fuses light science with sleep science to help adjust your body clock. Their flagship products include a non-contact sleep tracker for sleep diagnostics and a portable light therapy device for treatment. The devices sync together for an automatic and customised sleep improvement programme. Team from Imperial College London. Accelerated by HAX. Mentored by Johnson & Johnson Innovation. Launching on Kickstarter in March 2017.

CoffeeExchange is a digital platform based in Shanghai, China, that connects coffee farmers directly with roasters, aiming to enhance transparency in the coffee industry. Established in 2018, the company utilizes technology to streamline the green coffee trading process, offering services such as coffee evaluation, logistics, customs clearance, quality inspections, and marketing support. By eliminating intermediaries, CoffeeExchange facilitates direct trade, allowing coffee producers to earn significantly higher revenues while providing roasters with a broader selection at reduced costs. The platform incorporates IoT supply chain tracking and freight consolidation to optimize logistics and enhance order management. Currently, CoffeeExchange has over 1,100 coffee roasters in China trading with selected producers from various countries, including Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador, and is in the process of expanding its operations to the USA, UK, and South Korea.

Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.

VisusNano Ltd. is a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for laser treatment after surgery, our project has the potential to revolutionise cataract surgery in both the human and veterinary markets.

Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.

Pushme Inc. is a manufacturer of swappable batteries specifically designed for bicycles, aiming to enhance urban mobility. Founded in 2016 and based in Bath, United Kingdom, the company operates as a subsidiary of Tier Mobility GmbH. Pushme focuses on addressing the challenges of energy distribution for small electric vehicles by establishing a network of battery swap stations. These stations allow local merchants to sell energy, providing convenient and instant recharging solutions across cities. The innovative approach not only supports the adoption of electric bicycles but also empowers individuals with access to electricity to contribute to sustainable transport. The team at Pushme comprises engineers, designers, and operations experts dedicated to developing efficient hardware solutions that improve cycling experiences and facilitate energy management.

Sana Health UK Limited develops a sleep mask for people with severe sleep problems caused by high anxiety or pain. The company offers Sana, a wearable device that allows the wearer to put themselves to sleep in 10 minutes. Its mask measures and tracks user’s overall state of health and vitality over time, and uses this measure to tailor the device to get user to deep relaxation and sleep fast. Sana Health UK Limited was founded in 2015 and is based in Dorchester, United Kingdom.

Size matters, or rather the uniformity of microparticles makes a big difference. A difference, for example, that can allow an eye surgery to become a outpatient event. MicroSpray technologies are making this a reality by decreasing the size of the drugs into uniform microspheres, which you can then inject into the eye with the smallest gauge needle rather than a more invasive tool. Currently, biopharmaceutical industries use costly chemical methods to manufacture microspheres, which rely on batch-type processes, have a low throughput and produce non-uniform particles. MicroSpray Technologies is developing a spray-manufacturing system which enables reproducible, tight and uniform control of particle size. Allowing clinicians to administer control over the rate at which drugs are delivered to patients, using novel slow release particle technologies.

Pushme Inc. is a manufacturer of swappable batteries specifically designed for bicycles, aiming to enhance urban mobility. Founded in 2016 and based in Bath, United Kingdom, the company operates as a subsidiary of Tier Mobility GmbH. Pushme focuses on addressing the challenges of energy distribution for small electric vehicles by establishing a network of battery swap stations. These stations allow local merchants to sell energy, providing convenient and instant recharging solutions across cities. The innovative approach not only supports the adoption of electric bicycles but also empowers individuals with access to electricity to contribute to sustainable transport. The team at Pushme comprises engineers, designers, and operations experts dedicated to developing efficient hardware solutions that improve cycling experiences and facilitate energy management.